These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18288757)

  • 21. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
    Lee MS; Cheng RK; Kandzari DE; Kirtane AJ
    Am J Cardiol; 2012 Jun; 109(12):1729-32. PubMed ID: 22465319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology.
    Palmerini T; Marzocchi A; Tamburino C; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli A; Briguori C; Vignali L; Di Pede F; Ramondo A; Inglese L; De Carlo M; Bolognese L; Benassi A; Palmieri C; Filippone V; Sangiorgi D; De Servi S
    Am J Cardiol; 2008 Dec; 102(11):1463-8. PubMed ID: 19026296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.
    Lee MS; Park KW; Kang SH; Sheiban I; Mahmud E; Thani KB; Cheng R; Cho JH; Jin DK; Gwon HC; Chae IH; Aragon J; Gillis K; Stone GW; Kim HS
    J Invasive Cardiol; 2012 Jul; 24(7):316-9. PubMed ID: 22781468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes.
    Tarantini G; Favaretto E; Gardin A; Napodano M; Isabella G; Panfili M; Gerosa G; Iliceto S; Ramondo A
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):396-402. PubMed ID: 18334895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of 5,674 patients treated with percutaneous coronary intervention and drug-eluting stents or coronary artery bypass graft surgery for unprotected left main coronary artery stenosis.
    Sá MP; Soares AM; Lustosa PC; Martins WN; Browne F; Ferraz PE; Vasconcelos FP; Lima RC
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):73-80. PubMed ID: 22518037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents.
    Palmerini T; Marzocchi A; Tamburino C; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli A; Briguori C; Vignali L; Di Pede F; Ramondo A; Inglese L; De Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; De Servi S
    Circ Cardiovasc Interv; 2008 Dec; 1(3):185-92. PubMed ID: 20031677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting.
    Dudek D; Heba G; Giszterowicz D; Rzeszutko Ł; Legutko J; Bartuś S; Chyrchel M; Dubiel JS
    Kardiol Pol; 2006 Sep; 64(9):929-36; discussion 937-8. PubMed ID: 17054024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology.
    Palmerini T; Alessi L; Rizzo N; Dangas G
    Catheter Cardiovasc Interv; 2012 May; 79(6):990-9. PubMed ID: 21805577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Vitrella G; Ferraro M; Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):436-9; discussion 440-1. PubMed ID: 15789401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience.
    Colombo P; Bruschi G; Sacco A; Oreglia J; De Marco F; Colombo T; Botta L; Macera F; Turazza F; Frigerio M; Martinelli L; Klugmann S
    Transplant Proc; 2010 May; 42(4):1286-90. PubMed ID: 20534283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting stent implantation in bifurcated lesions with balloon-crushing technique and 6 fr guiding catheter: immediate and mid-term results.
    Lozano I; Avanzas P; Lee DH; Lasa G; Rondán J; Moris C
    J Invasive Cardiol; 2007 Jan; 19(1):27-31. PubMed ID: 17297182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW;
    J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Percutaneous Coronary Intervention in the Treatment of Cardiac Allograft Vasculopathy.
    Lee MS; Lluri G; Finch W; Park KW
    Am J Cardiol; 2018 May; 121(9):1051-1055. PubMed ID: 29598855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.